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ABSTRACT 
 
Background 
Hospital emergency departments play a crucial role in the initial management of suspected COVID-
19 infection. We aimed to characterise patients attending emergency departments with suspected 
COVID-19, including subgroups based on sex, ethnicity and COVID-19 test results. 
 
Methods 
We undertook a mixed prospective and retrospective observational cohort study in 70 emergency 
departments across the United Kingdom (UK). We collected presenting data from 22446 people 
attending with suspected COVID-19 between 26 March 2020 and 28 May 2020. Outcomes were 
admission to hospital, COVID-19 result, organ support (respiratory, cardiovascular or renal), and 
death, by record review at 30 days. 
 
Results 
Adults were acutely unwell (median NEWS2 score 4) and had high rates of admission (67.1%), 
COVID-19 positivity (31.2%), organ support (9.8%) and death (15.9%). Children had much lower rates 
of admission (27.4%), COVID-19 positivity (1.2%), organ support (1.4%) and death (0.3%). Adult men 
and women presented in similar numbers (10210 versus 10506), but men were more likely to be 
admitted (72.9% v 61.4%), require organ support (12.2% v 7.7%) and die (18.7% v 13.3%). Black or 
Asian adults tended to be younger than White adults (median age 54, 50 and 67 years), were less 
likely to be admitted (60.8%, 57.3%, 69.6%) or die (11.9%, 11.2%, 16.8%), but were more likely to 
require organ support (15.9%, 14.3%, 8.9%) or have a positive COVID-19 test (40.8%, 42.1%, 30.0%).  
Adults admitted with confirmed COVID-19 had similar age and comorbidities (except chronic lung 
disease) to those who did not have COVID-19 confirmed, but were much more likely to need organ 
support (22.2% v 8.9%) or die (32.7% v 15.9%). 
 
Conclusions 
Important differences exist between patient groups presenting to the emergency department with 
suspected COVID-19. People with confirmed COVID-19 have a poor prognosis, compared with similar 
emergency admissions without confirmed COVID-19. 
 
Registration 
ISRCTN registry, ISRCTN56149622, http://www.isrctn.com/ISRCTN28342533  
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INTRODUCTION 
Hospital emergency departments (ED) have played a crucial role during the COVID-19 pandemic in 
receiving acutely ill patients, determining the need for admission and critical care, and providing 
emergency treatment. International [1,2] and national [3-6] guidelines have been developed for the 
emergency management of suspected COVID-19. 
 
Studies of hospitalised cases with COVID-19 [7-10] inform the emergency management of suspected 
COVID-19 but have important limitations. First, patients typically present with suspected rather than 
proven COVID-19. This presentation includes many patients with characteristics of COVID-19, who 
need urgent care, but do not ultimately have the virus. Second, emergency management involves 
differentiating those with severe illness who require hospital admission from those with mild or 
moderate illness who can be managed at home. Appropriate management of this heterogeneous 
population is an important challenge that needs to be informed by relevant data. 
 
The Pandemic Respiratory Infection Emergency System Triage (PRIEST) study collected data from 
consecutive patients attending EDs across the UK with suspected COVID-19. We aimed to 
characterise patients attending EDs with suspected COVID-19, including subgroups based on sex, 
ethnicity and COVID-19 results. 
 
MATERIALS AND METHODS 
The PRIEST study was originally set up and piloted as the Pandemic Influenza Triage in the 
Emergency Department (PAINTED) study as part of the UK National Institute for Health Research 
(NIHR) pandemic portfolio of studies to be activated in the event of an influenza pandemic [11,12]. It 
was developed into the PRIEST study and expanded to include other respiratory infections in 
response to the emerging COVID-19 pandemic. 
 
We undertook an observational cohort study of adults and children attending the ED with suspected 
COVID-19 infection. Patients were included if the assessing clinician recorded that the patient had 
suspected COVID-19 in the ED records or completed a standardised assessment form for suspected 
COVID-19 patients. The clinical diagnostic criteria for COVID-19 during the study were of fever 
(≥ 37.8°C) and at least one of the following respiratory symptoms, which must be of acute onset: 
persistent cough (with or without sputum), hoarseness, nasal discharge or congestion, shortness of 
breath, sore throat, wheezing, sneezing. We did not seek consent to collect data but information 
about the study was provided in the ED and patients could withdraw their data at their request. 
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Patients with multiple presentations to hospital were only included once, using data from the first 
presentation identified by research staff. 
 
Baseline characteristics at presentation to the ED were recorded prospectively, using a standardised 
assessment form developed and piloted for the PAINTED study [12] that doubled as a clinical record 
(Appendix 2), or retrospectively, through research staff extracting data onto the standardised form 
using the clinical records. Research staff collected follow-up data onto a standardised follow-up form 
(Appendix 3) using clinical records up to 30 days after presentation. They then entered data onto a 
secure online database managed by the Sheffield Clinical Trials Research Unit (CTRU). 
 
Patients who died or required respiratory, cardiovascular or renal support were classified as having 
an adverse outcome. Patients who survived to 30 days without requiring respiratory, cardiovascular 
or renal support were classified as having no adverse outcome. Respiratory support was defined as 
any intervention to protect the patient’s airway or assist their ventilation, including non-invasive 
ventilation or acute administration of continuous positive airway pressure. It did not include 
supplemental oxygen alone or nebulised bronchodilators. Cardiovascular support was defined as any 
intervention to maintain organ perfusion, such as inotropic drugs, or invasively monitor 
cardiovascular status, such as central venous pressure or pulmonary artery pressure monitoring, or 
arterial blood pressure monitoring. It did not include peripheral intravenous cannulation or fluid 
administration. Renal support was defined as any intervention to assist renal function, such as 
haemofiltration, haemodialysis or peritoneal dialysis. It did not include intravenous fluid 
administration. 
 
The sample size was determined by the size and severity of the pandemic, but was originally planned 
to involve recruiting 20,000 patients across 40 sites. This was expected to include 200 with an 
adverse outcome, based on a 1% prevalence of adverse outcome in a previous study undertaken 
during the 2009 H1N1 pandemic. 
 
This paper presents a descriptive analysis of the cohort. We calculated a National Early Warning 
Score (2
nd
 version, NEWS2) for adults, to provide an overall assessment of acute illness severity on a 
scale from zero to 20, based on respiratory rate, oxygen saturation, systolic blood pressure, heart 
rate, level of consciousness and temperature [13]. We calculated a modified Paediatric Observation 
Priority Score (POPS) for children for the same purpose, with a scale from zero to 14, based on 
respiratory rate, oxygen saturation, heart rate, level of consciousness, temperature, breathing and 
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past medical history (excluding the gut feeling parameter) [14]. We undertook descriptive analysis of 
subgroups based on age, sex and ethnicity. We also compared the characteristics and outcomes of 
admitted patients with positive COVID-19 testing to those with negative or no testing. 
 
Patient and public involvement 
The Sheffield Emergency Care Forum (SECF) is a public representative group interested in emergency 
care research. [15] Members of SECF advised on the development of the PRIEST study and two 
members joined the Study Steering Committee. Patients were not involved in the recruitment to and 
conduct of the study. We are unable to disseminate the findings to study participants directly. 
 
RESULTS 
The PRIEST study recruited 22485 patients from 70 EDs across 53 sites between 26 March 2020 and 
28 May 2020. We included 22446 in the analysis after excluding 39 who requested withdrawal of 
their data. The mean age was 58.4 years, 11200 (50.4%) were female, 11035 (49.6%) male (211 
missing), and ethnicity was 15198 (84.7%) UK/Irish/other white, 1150 (6.4%) Asian, 692 (3.9%) 
Black/African/Caribbean, 328 (1.8%) mixed/multiple ethnic groups, 570 (3.2%) other ethnic groups 
and 4508 unknown (missing data or preferring not to say). After ED assessment COVID-19 was 
considered the most likely diagnosis for 14401 (67.2% of those with non-missing data). Figure 1 
shows that hourly presentations between 11:00 and 18:00 were around four times the night-time 
rate. 
 
Table 1 shows the baseline characteristics, presenting features and physiology of adults and children 
in the cohort, and Table 2 shows the admission decisions and adverse outcomes for adults and 
children. Figure 2 shows the NEWS2 score for adults and Figure 3 shows the POPS score for children. 
The median (inter-quartile range [IQR]) NEWS2 score was 4 (2, 7) for adults and the median POPS 
score was 1 (1, 3) for children. 
 
 
Table 1: Baseline characteristics, presenting features and physiology of adults (N=20909) and 
children (N=1530)† 
 
Characteristic Statistic/level Adults Children 
Age (years) N 20909 1530 
 Mean (SD) 62.4 (19.7) 3.6 (4.2) 
 Median (IQR) 64 (48,79) 2 (0,6) 
Sex Missing 193 18 
 Male 10210 (49.3%) 821 (54.3%) 
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 Female 10506 (50.7%) 691 (45.7%) 
Ethnicity Missing/prefer not to say 4216 290 
 UK/Irish/other white 14243 (85.3%) 950 (76.6%) 
 Asian 1044 (6.3%) 106 (8.5%) 
 Black/African/Caribbean 640 (3.8%) 52 (4.2%) 
 Mixed/multiple ethnic groups 247 (1.5%) 81 (6.5%) 
 Other 519 (3.1%) 51 (4.1%) 
Presenting features Cough 12995 (62.2%) 580 (37.9%) 
 Shortness of breath 15586 (74.5%) 314 (20.5%) 
 Fever 10282 (49.2%) 1222 (79.9%) 
Symptom duration (days) N 18890 1442 
 Mean (SD) 7.9 (8.9) 4.3 (5.9) 
 Median (IQR) 5 (2,10) 2 (1,5) 
Heart rate (beats/min) N 20478 1482 
 Mean (SD) 94.9 (21.6) 137.2 (28.4) 
 Median (IQR) 93 (80,108) 138 (118,157) 
Respiratory rate (breaths/min) N 20364 1473 
 Mean (SD) 23.3 (7) 33.1 (10.3) 
 Median (IQR) 22 (18,26) 32 (26,40) 
Systolic BP (mmHg) N 20316 376 
 Mean (SD) 134.6 (24.9) 107.9 (15.2) 
 Median (IQR) 133 (118,149) 109 (98,117) 
Diastolic BP (mmHg) N 20229 366 
 Mean (SD) 78.2 (16.1) 65.3 (12.4) 
 Median (IQR) 78 (68,88) 64 (58,73) 
Temperature (°C)  N 20249 1485 
 Mean (SD) 37.1 (1.1) 37.5 (1.1) 
 Median (IQR) 37 (36.4,37.8) 37.4 (36.7,38.3) 
Oxygen saturation (%) N 20650 1498 
 Mean (SD) 94.7 (6.8) 97.7 (3.1) 
 Median (IQR) 96 (94,98) 98 (97,99) 
Glasgow Coma Scale N 15435 506 
 Mean (SD) 14.6 (1.4) 14.9 (0.9) 
 Median (IQR) 15 (15,15) 15 (15,15) 
AVPU Missing 2391 120 
 Alert 17581 (94.9%) 1394 (98.9%) 
 Verbal 640 (3.5%) 11 (0.8%) 
 Pain 183 (1%) 3 (0.2%) 
 Unresponsive 114 (0.6%) 2 (0.1%) 
†N=7 omitted due to missing age 
 
 
Table 2: Outcomes of adults (N=20909) and children (N=1530) 
 
Outcome Level Adult N (%) Child N (%) 
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Admitted at initial assessment Missing 45 3 
No 6867 (32.9%) 1109 (72.6%) 
Yes 13997 (67.1%) 418 (27.4%) 
Respiratory pathogen COVID-19 6521 (31.2%) 19 (1.2%) 
Influenza 27 (0.1%) 2 (0.1%) 
Other 1721 (8.2%) 237 (15.5%) 
None identified 12640 (60.5%) 1272 (83.1%) 
Mortality status Missing 20 3 
Alive 17569 (84.1%) 1523 (99.7%) 
Dead 3320 (15.9%) 4 (0.3%) 
    Death with organ support* 706 (21.3%) 0 (0%) 
    Death with no organ support* 2614 (78.7%) 4 (100%) 
Organ support Respiratory 1944 (9.3%) 18 (1.2%) 
Cardiovascular 517 (2.5%) 8 (0.5%) 
Renal 218 (1%) 2 (0.1%) 
 Any 2058 (9.8%) 22 (1.4%) 
*Denominator=total deaths in category 
 
 
Adults with suspected COVID-19 were acutely unwell, with a lower IQR oxygen saturation of 94% 
and an upper IQR respiratory rate of 26/minute, and had high rates of admission (67.1%), organ 
support (9.8%) and death (15.9%). Children with suspected COVID-19 also presented with abnormal 
physiology, but had low rates of admission, organ support and mortality. Adults tended to present 
with cough and breathlessness, while children tended to present with fever. Very few children had a 
positive test for COVID-19, compared with almost a third of adults. 
 
Table 3 shows that adults with suspected COVID-19 had substantial co-morbidities (30.8% with 
hypertension and 19.7% with diabetes) and almost half were recorded as having some limitation of 
normal activities. A substantial proportion (19.3%) had a Do Not Attempt Resuscitation decision 
recorded on or before the day of presentation. 
 
 
Table 3: Co-morbidities, performance status and Do Not Attempt Resuscitation decisions for adults 
(N=20909) 
 
Characteristic Level N (%) 
Comorbidities Hypertension 6438 (30.8%) 
Heart Disease 4702 (22.5%) 
Diabetes 4129 (19.7%) 
Other chronic lung disease 3767 (18%) 
Asthma 3410 (16.3%) 
Renal impairment 1934 (9.2%) 
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Active malignancy 1120 (5.4%) 
Immunosuppression 631 (3%) 
Steroid therapy 557 (2.7%) 
No Chronic disease 5798 (27.7%) 
Performance status Missing 1081 
Unrestricted normal activity 10541 (53.2%) 
Limited strenuous activity, can do light 2373 (12%) 
Limited activity, can self care 2781 (14%) 
Limited self care 2649 (13.4%) 
Bed/chair bound, no self care 1484 (7.5%) 
DNAR in place after 
ED assessment  4029 (19.3%) 
 
 
Table 4 shows that men tended to be older than women, have slightly more severe illness, and were 
more likely to have hypertension, heart disease, diabetes or chronic lung disease, while women were 
more likely to have asthma. Men and women attended the ED in similar numbers, but men were 
more likely to be admitted, have positive COVID-19 testing, require organ support and die. 
 
 
Table 4: Characteristics and outcomes of male (N=10210) and female (N=10506) adults† 
 
Characteristic  Statistic/level Adult men Adult women 
Age (years) N 10210 10506 
 Mean (SD) 64 (18.3) 60.8 (20.9) 
 Median (IQR) 66 (51,79) 61 (45,79) 
Presenting features Cough 6407 (62.8%) 6473 (61.6%) 
 Shortness of breath 7646 (74.9%) 7811 (74.3%) 
 Fever 5224 (51.2%) 4969 (47.3%) 
Symptom duration (days) N 9216 9501 
 Mean (SD) 7.6 (8.5) 8.3 (9.2) 
 Median (IQR) 5 (2,10) 5 (2,10) 
Respiratory rate (breaths/min) N 9952 10228 
 Mean (SD) 23.7 (7.3) 22.8 (6.7) 
 Median (IQR) 22 (18,27) 21 (18,26) 
Oxygen saturation (%) N 10095 10367 
 Mean (SD) 94.2 (7) 95.1 (6.6) 
 Median (IQR) 96 (93,98) 97 (94,98) 
NEWS2 score N 10119 10304 
 Mean (SD) 4.7 (3.4) 4.1 (3.2) 
 Median (IQR) 4 (2,7) 4 (1,6) 
Comorbidities Hypertension 3357 (32.9%) 3013 (28.7%) 
 Heart Disease 2718 (26.6%) 1945 (18.5%) 
 Diabetes 2343 (22.9%) 1747 (16.6%) 
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 Other chronic lung disease 1981 (19.4%) 1760 (16.8%) 
 Asthma 1261 (12.4%) 2117 (20.2%) 
 Renal impairment 1029 (10.1%) 888 (8.5%) 
 Active malignancy 659 (6.5%) 453 (4.3%) 
 Immunosuppression 294 (2.9%) 333 (3.2%) 
 Steroid therapy 248 (2.4%) 305 (2.9%) 
 No Chronic disease 2659 (26%) 3080 (29.3%) 
Performance status Missing 531 539 
 Unrestricted normal activity 5005 (51.7%) 5437 (54.6%) 
 Limited strenuous activity, can do light 1216 (12.6%) 1134 (11.4%) 
 Limited activity, can self care 1420 (14.7%) 1339 (13.4%) 
 Limited self care 1315 (13.6%) 1308 (13.1%) 
 Bed/chair bound, no self care 723 (7.5%) 749 (7.5%) 
Admitted at initial assessment Missing 22 23 
 No 2766 (27.1%) 4043 (38.6%) 
 Yes 7422 (72.9%) 6440 (61.4%) 
Respiratory pathogen COVID-19 3612 (35.4%) 2851 (27.1%) 
 Influenza (pandemic or seasonal) 10 (0.1%) 17 (0.2%) 
 Other 809 (7.9%) 902 (8.6%) 
 None identified 5779 (56.6%) 6736 (64.1%) 
Mortality status Missing 9 11 
 Alive 8298 (81.3%) 9103 (86.7%) 
 Dead 1903 (18.7%) 1392 (13.3%) 
     Death with organ support* 448 (23.5%) 254 (18.2%) 
     Death with no organ support* 1455 (76.5%) 1138 (81.8%) 
Organ support Respiratory 1165 (11.4%) 769 (7.3%) 
 Cardiovascular 360 (3.5%) 151 (1.4%) 
 Renal 155 (1.5%) 61 (0.6%) 
 Any 1241 (12.2%) 805 (7.7%) 
†N=193 omitted due to missing sex 
*Denominator=total deaths in category 
 
 
Table 5 reports the characteristics and outcomes of adults in different ethnic groups. Black or Asian 
adults tended to be younger than White adults, were less likely to have impaired performance status, 
be admitted to hospital or die, but were more likely to require organ support or have a positive 
COVID-19 test. Comorbidities also varied between ethnic groups. 
 
Table 6 shows the characteristics and outcomes of admitted adults with subsequent positive COVID-
19 testing and admitted patients with negative or no testing. Age and comorbidities (except chronic 
lung disease) did not differ markedly between the two groups, but adults with confirmed COVID-19 
were more likely to die or require organ support. 
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Table 5: Characteristics and outcomes of different ethnic groups among adults 
Characteristic Statistic/level 
UK/Irish/ 
other white 
Asian 
Black/ 
African/ 
Caribbean 
Mixed/ 
Multiple 
groups 
Other Unknown 
Age (years) N 14243 1044 640 247 519 4216 
 Mean (SD) 64.5 (19.5) 52.8 (17.8) 55 (17.7) 52.8 (19.3) 51.2 (18.5) 60.6 (19.7) 
 Median (IQR) 67 (51,81) 50 (40,66) 54 (41.5,67) 52 (36,69) 48 (38,64) 61 (46,77) 
Sex Missing 129 11 6 4 5 38 
 Male 6858 (48.6%) 531 (51.4%) 309 (48.7%) 104 (42.8%) 269 (52.3%) 2139 (51.2%)
 Female 7256 (51.4%) 502 (48.6%) 325 (51.3%) 139 (57.2%) 245 (47.7%) 2039 (48.8%)
Presenting features Cough 8749 (61.4%) 717 (68.7%) 386 (60.3%) 155 (62.8%) 342 (65.9%) 2646 (62.8%)
 Shortness of breath 10662 (74.9%) 765 (73.3%) 442 (69.1%) 178 (72.1%) 388 (74.8%) 3151 (74.7%)
 Fever 6756 (47.4%) 650 (62.3%) 329 (51.4%) 127 (51.4%) 288 (55.5%) 2132 (50.6%)
Symptom duration (days) N 12891 988 601 232 494 3684 
 Mean (SD) 7.6 (8.7) 9.3 (8.9) 9.1 (9.5) 8.8 (8.8) 8.7 (7.7) 8.3 (9.5) 
 Median (IQR) 5 (2,10) 7 (3,13) 7 (3,14) 7 (3,10.5) 7 (3,12) 6 (2,10) 
Respiratory rate (breaths/min) N 13898 1013 617 239 502 4095 
 Mean (SD) 23.2 (6.8) 24.2 (8.2) 23.7 (7.8) 22.5 (7.2) 22.4 (6.6) 23.3 (7.1) 
 Median (IQR) 22 (18,26) 22 (18,28) 21 (18,28) 20 (18,25) 20 (18,24) 21 (18,26) 
Oxygen saturation (%) N 14079 1031 634 245 513 4148 
 Mean (SD) 94.5 (6.9) 95 (7.6) 95.3 (7) 95.6 (5.9) 95.5 (6.4) 94.8 (6.4) 
 Median (IQR) 96 (94,98) 97 (95,98) 97 (95,99) 97 (95,99) 97 (95,98) 96 (94,98) 
NEWS2 score N 14062 1021 632 241 509 4147 
 Mean (SD) 4.5 (3.3) 4.2 (3.3) 4.1 (3.3) 3.8 (3.3) 3.7 (3.2) 4.4 (3.3) 
 Median (IQR) 4 (2,7) 4 (1,6) 4 (1,6) 3 (1,6) 3 (1,6) 4 (2,7) 
Comorbidities Hypertension 4576 (32.1%) 338 (32.4%) 253 (39.5%) 61 (24.7%) 105 (20.2%) 1105 (26.2%)
 Heart Disease 3563 (25%) 158 (15.1%) 66 (10.3%) 28 (11.3%) 56 (10.8%) 831 (19.7%) 
 Diabetes 2743 (19.3%) 334 (32%) 175 (27.3%) 59 (23.9%) 67 (12.9%) 751 (17.8%) 
 Other chronic lung disease 2938 (20.6%) 70 (6.7%) 45 (7%) 29 (11.7%) 47 (9.1%) 638 (15.1%) 
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 Asthma 2400 (16.9%) 160 (15.3%) 99 (15.5%) 36 (14.6%) 63 (12.1%) 652 (15.5%) 
 Renal impairment 1415 (9.9%) 86 (8.2%) 63 (9.8%) 17 (6.9%) 23 (4.4%) 330 (7.8%) 
 Active malignancy 865 (6.1%) 26 (2.5%) 22 (3.4%) 7 (2.8%) 12 (2.3%) 188 (4.5%) 
 Immunosuppression 445 (3.1%) 33 (3.2%) 29 (4.5%) 7 (2.8%) 13 (2.5%) 104 (2.5%) 
 Steroid therapy 414 (2.9%) 19 (1.8%) 14 (2.2%) 4 (1.6%) 15 (2.9%) 91 (2.2%) 
 No Chronic disease 3452 (24.2%) 380 (36.4%) 189 (29.5%) 97 (39.3%) 257 (49.5%) 1423 (33.8%)
Performance status Missing 706 28 13 6 21 307 
 Unrestricted normal activity 6549 (48.4%) 744 (73.2%) 356 (56.8%) 180 (74.7%) 367 (73.7%) 2345 (60%) 
 Limited strenuous activity, can do light 1755 (13%) 84 (8.3%) 81 (12.9%) 22 (9.1%) 40 (8%) 391 (10%) 
 Limited activity, can self care 2095 (15.5%) 79 (7.8%) 70 (11.2%) 23 (9.5%) 36 (7.2%) 478 (12.2%) 
 Limited self care 2058 (15.2%) 50 (4.9%) 54 (8.6%) 9 (3.7%) 32 (6.4%) 446 (11.4%) 
 Bed/chair bound, no self care 1080 (8%) 59 (5.8%) 66 (10.5%) 7 (2.9%) 23 (4.6%) 249 (6.4%) 
Admitted at initial assessment Missing 22 1 0 0 0 22 
 No 4329 (30.4%) 445 (42.7%) 251 (39.2%) 108 (43.7%) 262 (50.5%) 1472 (35.1%)
 Yes 9892 (69.6%) 598 (57.3%) 389 (60.8%) 139 (56.3%) 257 (49.5%) 2722 (64.9%)
Respiratory pathogen COVID-19 4278 (30%) 440 (42.1%) 261 (40.8%) 68 (27.5%) 170 (32.8%) 1304 (30.9%)
 Influenza (pandemic or seasonal) 23 (0.2%) 1 (0.1%) 0 (0%) 0 (0%) 0 (0%) 3 (0.1%) 
 Other 1361 (9.6%) 65 (6.2%) 29 (4.5%) 16 (6.5%) 19 (3.7%) 231 (5.5%) 
 None identified 8581 (60.2%) 538 (51.5%) 350 (54.7%) 163 (66%) 330 (63.6%) 2678 (63.5%)
Mortality status Missing 3 0 0 0 0 17 
 Alive 11847 (83.2%) 927 (88.8%) 564 (88.1%) 220 (89.1%) 473 (91.1%) 3538 (84.3%)
 Dead 2393 (16.8%) 117 (11.2%) 76 (11.9%) 27 (10.9%) 46 (8.9%) 661 (15.7%) 
     Death with organ support* 450 (18.8%) 40 (34.2%) 32 (42.1%) 13 (48.1%) 17 (37%) 154 (23.3%) 
     Death with no organ support* 1943 (81.2%) 77 (65.8%) 44 (57.9%) 14 (51.9%) 29 (63%) 507 (76.7%) 
Organ support Respiratory 1189 (8.3%) 139 (13.3%) 93 (14.5%) 31 (12.6%) 53 (10.2%) 439 (10.4%) 
 Cardiovascular 278 (2%) 58 (5.6%) 45 (7%) 5 (2%) 14 (2.7%) 117 (2.8%) 
 Renal 115 (0.8%) 22 (2.1%) 31 (4.8%) 3 (1.2%) 5 (1%) 42 (1%) 
 Any 1264 (8.9%) 149 (14.3%) 102 (15.9%) 34 (13.8%) 53 (10.2%) 456 (10.8%) 
*Denominator=total deaths in category 
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Table 6: Characteristics and outcomes of admitted adult patients with (N=5768) and without 
(N=8229) positive COVID-19 test  
 
Characteristic Statistic/level 
COVID-19 positive 
COVID-19 
negative  
or not tested 
Age (years) N 5768 8229 
 Mean (SD) 69.8 (16.6) 68.4 (17.8) 
 Median (IQR) 73 (58,83) 72 (57,82) 
Sex Missing 53 82 
 Male 3282 (57.4%) 4140 (50.8%) 
 Female 2433 (42.6%) 4007 (49.2%) 
Presenting features Cough 3722 (64.5%) 4633 (56.3%) 
 Shortness of breath 4390 (76.1%) 6158 (74.8%) 
 Fever 3425 (59.4%) 3629 (44.1%) 
Symptom duration (days) N 5199 7278 
 Mean (SD) 6.9 (6.3) 7 (8.9) 
 Median (IQR) 6 (2,10) 3 (2,8) 
Respiratory rate (breaths/min) N 5634 8060 
 Mean (SD) 25.6 (7.8) 23.9 (6.9) 
 Median (IQR) 24 (20,29) 22 (19,28) 
Oxygen saturation (%) N 5710 8152 
 Mean (SD) 92.7 (7.8) 94.1 (7) 
 Median (IQR) 95 (91,97) 96 (93,98) 
NEWS2 score N 5711 8146 
 Mean (SD) 6.1 (3.2) 5.2 (3.2) 
 Median (IQR) 6 (4,8) 5 (3,7) 
Comorbidities Hypertension 2251 (39%) 3000 (36.5%) 
 Heart Disease 1605 (27.8%) 2457 (29.9%) 
 Diabetes 1591 (27.6%) 1885 (22.9%) 
 Other chronic lung disease 978 (17%) 2189 (26.6%) 
 Asthma 770 (13.3%) 1276 (15.5%) 
 Renal impairment 769 (13.3%) 959 (11.7%) 
 Active malignancy 282 (4.9%) 693 (8.4%) 
 Immunosuppression 181 (3.1%) 309 (3.8%) 
 Steroid therapy 160 (2.8%) 288 (3.5%) 
 No Chronic disease 1158 (20.1%) 1406 (17.1%) 
Performance status Missing 232 504 
 Unrestricted normal activity 2224 (40.2%) 2989 (38.7%) 
 
Limited strenuous activity, can 
do light 605 (10.9%) 1160 (15%) 
 Limited activity, can self care 856 (15.5%) 1625 (21%) 
 Limited self care 1128 (20.4%) 1286 (16.6%) 
 Bed/chair bound, no self care 723 (13.1%) 665 (8.6%) 
Mortality status Missing 0 1 
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 Alive 3881 (67.3%) 6916 (84.1%) 
 Dead 1887 (32.7%) 1312 (15.9%) 
     Death with organ support* 478 (25.3%) 214 (16.3%) 
     Death with no organ support* 1409 (74.7%) 1098 (83.7%) 
Organ support Respiratory 1235 (21.4%) 661 (8%) 
 Cardiovascular 379 (6.6%) 128 (1.6%) 
 Renal 151 (2.6%) 65 (0.8%) 
 Any 1278 (22.2%) 729 (8.9%) 
*Denominator=total deaths in category 
 
 
 
DISCUSSION 
Our study describes the presentation of suspected COVID-19 to EDs across the United Kingdom over 
the first wave of the pandemic. This large, generalizable cohort allows us to characterise the 
challenge faced by EDs, identify important differences between demographic groups and guide 
planning for future emergency care. 
 
Adults presenting to the ED with suspected COVID-19 tended to have severe illness, with relatively 
high NEWS2 scores and abnormal respiratory physiology, and a correspondingly high rate of 
admission and adverse outcome. Children had a much lower rate of admission and a very low rate of 
adverse outcome. Adults were also much more likely to have confirmed COVID-19 than children. 
Suspected COVID-19 in adults and children could therefore be considered as different entities, 
requiring different approaches to triage, diagnosis and management. 
 
A number of policies were implemented during the pandemic to reduce unnecessary ED attendances 
with suspected COVID-19. The UK National Health Service advised people with suspected COVID-19 
to use the online or telephone NHS111 service rather than attend the ED directly. Some ambulance 
services avoided transferring people to the ED if they did not have features of severe disease. Our 
findings suggest that these approaches resulted in an adult ED population with severe illness and 
high rate of admission. Further research is underway as part of the PRIEST study to determine 
whether this was achieved at the expense of delayed hospital admission for some cases. 
 
Adults admitted with suspected COVID-19 that was subsequently confirmed were more than twice 
as likely to die or receive organ support as those who did not have COVID-19 confirmed, despite 
having similar age and comorbidities (expect chronic lung disease). Admission with COVID-19 
therefore confers a markedly worse prognosis compared to similar presentations. We are only 
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aware of one other study comparing ED presentations in this way – a small single centre study from 
San Francisco showing no difference in mortality. [16] 
 
Adult men and women presented to the ED with suspected COVID-19 in almost equal numbers, but 
men were more likely to be admitted, have positive COVID-19 testing, receive organ support and die. 
This may be explained by age and comorbidities. Previous studies have shown a male majority of 
around 60% among admitted patients. [7-10, 17-19] Petrilli et al included patients managed as 
outpatients or discharged from the ED in their cohort and report similar findings to us, with an equal 
ratio presenting but men more likely to be admitted. [20] 
 
Black or Asian adults tended to be younger than White adults, had less impairment of performance 
status, and were less likely to be admitted to hospital or die, but were more likely to require organ 
support or have a positive COVID-19 test. A recent systematic review [21] suggested Black or Asian 
people are at an increased risk of acquiring COVID-19 and a greater risk of worse clinical outcomes 
compared to White people. Harrison et al studied admitted patients with a high likelihood of COVID-
19 infection across UK hospitals over the same time period as our study and showed that higher 
mortality among the White population was explained by age on multivariable analysis. [Harrison] In 
contrast, Price-Heywood et al found that high mortality associated with Black ethnicity in Louisiana 
was explained by sociodemographic and clinical characteristics [22], while Petrelli et al showed that 
Hispanic ethnicity in New York was associated with an increased risk of hospital admission but not of 
critical illness. [20] These findings suggest a complex interaction between underlying demographics 
and comorbidities, susceptibility to COVID-19 and use of health services may explain differences 
between ethnic groups. 
 
Our study is based on a large and generalizable cohort covering the first wave of the pandemic, but 
has some limitations. A combination of prospective and retrospective data collection was used, and 
infection control measures limited our ability to collect data directly from patients. Reliance on 
clinical records may have underestimated the prevalence of some presenting features and co-
morbidities, and resulted in missing data for some variables. Selection of cases was based on 
subjective clinical judgement that COVID-19 was a suspected diagnosis, which may have been 
applied in a variable manner between clinicians and between sites. Our analysis was limited to 
describing the cohort rather than using multivariable analysis to explain the observed differences 
between groups. We felt that the latter analysis would need to be based on a clear theoretical 
rationale and inclusion of appropriate covariates, which would be beyond the scope of this study. 
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In summary, we have shown important differences between patient groups presenting to the ED 
with suspected COVID-19. Adults and children differ markedly and require different approaches to 
emergency triage. Admission and adverse outcome rates among adults suggest that policies to avoid 
unnecessary ED attendance achieved their aim. Subsequent COVID-19 confirmation confers a worse 
prognosis and greater need for organ support.  
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Figure 1: Time of presentation to the ED 
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Figure 2: Adult patients NEWS2 scores 
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Figure 3: Child patient POPS scores 
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